25/100 SP 342 (Parcopa 25 mg / 100 mg)
Generic Name: carbidopa/levodopa
Pill imprint 25/100 SP 342 has been identified as Parcopa 25 mg / 100 mg.
Parcopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- carbidopa/levodopa
- Imprint:
- 25/100 SP 342
- Strength:
- 25 mg / 100 mg
- Color:
- Yellow
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Schwarz Pharma
- National Drug Code (NDC):
- 00091-3342
- Inactive Ingredients:
- aspartame
citric acid
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
natural mint flavor
artificial mint flavor
sodium bicarbonate
More about Parcopa (carbidopa / levodopa)
Consumer resources
- Other brands: Sinemet, Rytary, Sinemet CR, Duopa
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
